Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
April 15, 2024 06:30 ET
|
Neumora Therapeutics, Inc.
WATERTOWN, Mass., April 15, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical...
Mobilicom to Unveil Unprecedented Comprehensive Solution for Uncrewed Vehicle Systems at AUVSI XPONENTIAL 2024
April 15, 2024 06:30 ET
|
Mobilicom Limited
Mobilicom is a member of The Association for Uncrewed Vehicle Systems International’s (AUVSI) Cybersecurity Working Group and is highly regarded as a leader in cybersecure solutions and standards...
Immuron to host Live Virtual Event
April 15, 2024 06:00 ET
|
Immuron Limited
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our...
Huize Partners with Ruihua Health Assurance to Launch “Darwin Critical Care No.9” – A Customized Critical Illness Insurance Product
April 15, 2024 05:00 ET
|
Huize Holding Limited
SHENZHEN, China, April 15, 2024 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance...
InterDigital and Concordia University Announce Research Collaboration on AI-enabled Immersive Media Delivery over 5G Networks
April 15, 2024 04:00 ET
|
InterDigital, Inc.
WILMINGTON, Del., April 15, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, and Concordia University’s Intelligent...
Aurora Mobile Limited Files Its Annual Report on Form 20-F
April 15, 2024 03:30 ET
|
Aurora Mobile Limited
SHENZHEN, China, April 15, 2024 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services...
PHAXIAM Therapeutics annonce le recrutement du premier patient dans l’étude de phase 1 dans l’endocardite infectieuse causée par le Staphylococcus aureus
April 15, 2024 01:30 ET
|
Phaxiam Therapeutics S.A.
L’étude prévoit l’inclusion de 12 patients dans 5 centres cliniques françaisLes premiers résultats sont attendus au 3ème trimestre 2024Cette étude permet d’évaluer l’administration intraveineuse...
PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus
April 15, 2024 01:30 ET
|
Phaxiam Therapeutics S.A.
The study plans for the enrolment of 12 patients in 5 French clinical centersFirst study results expected in Q3 2024This study will enable an evaluation of the intravenous administration of phages,...
Forian Inc. Announces the Passing of Director Martin J. Wygod
April 14, 2024 18:03 ET
|
Forian Inc.
NEWTOWN, PA, April 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq:FORA), a provider of data science driven information and analytics solutions to the healthcare and life...
Research: More than Half of Singapore’s Organisations Experienced 1-2 hours of Weekly Downtime Due to Fixed Line/ Fibre Network Failure Over the Last 12 months
April 14, 2024 16:30 ET
|
Cradlepoint
MELBOURNE, Australia, April 14, 2024 (GLOBE NEWSWIRE) -- Cradlepoint, part of Ericsson, the global leader in cloud-delivered LTE and 5G wireless network and security solutions, today announced...